1 / 4

Osteoscoop - Issue N°276 – February 2013

Acetylcholinesterase inhibitors and the risk of hip fracture in Alzheimer’s disease patients: a case-control study. Osteoscoop - Issue N°276 – February 2013. Ach. AchR. Preosteoblasts. AchE. Ach degradation. +. Monocytes. Osteoblasts. Osteoclasts. Osteocytes. Ach. AchR.

xena
Download Presentation

Osteoscoop - Issue N°276 – February 2013

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Acetylcholinesterase inhibitors and the risk of hip fracture in Alzheimer’s disease patients: a case-control study Osteoscoop - Issue N°276 – February 2013

  2. Ach AchR Preosteoblasts AchE Achdegradation + Monocytes Osteoblasts Osteoclasts Osteocytes

  3. Ach AchR Preosteoblasts AchE Achdegradation + Monocytes Osteoblasts Osteoclasts Osteocytes Alzheimer patients (age >75 years) TreatedwithAchEinhibitor (Donepezil; Rivastigmine) Treatedwithothermolecules

  4. Ach AchR Preosteoblasts AchE Achdegradation + Monocytes Osteoblasts Osteoclasts Osteocytes Alzheimer patients (age >75 years) TreatedwithAchEinhibitor (Donepezil; Rivastigmine) Treatedwithothermolecules 1,00 0,49 HIP FRACTURE RISK

More Related